@article{4e4330a05c0e44e8825bfc17a55d8b76,
title = "Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working Group",
author = "Shinsuke Hirabayashi and Butler, \{Ellie R.\} and Kentaro Ohki and Nobutaka Kiyokawa and Bergmann, \{Anke K.\} and Anja M{\"o}ricke and Boer, \{Judith M.\} and H{\'e}l{\`e}ne Cav{\'e} and Giovanni Cazzaniga and Yeoh, \{Allen Eng Juh\} and Masashi Sanada and Toshihiko Imamura and Hiroto Inaba and Charles Mullighan and Loh, \{Mignon L.\} and Ulrika Nor{\'e}n-Nystr{\"o}m and Agata Pastorczak and Shih, \{Lee Yung\} and Marketa Zaliova and Pui, \{Ching Hon\} and Haas, \{Oskar A.\} and Harrison, \{Christine J.\} and Moorman, \{Anthony V.\} and Atsushi Manabe",
note = "Funding Information: Japan, Blood Cancer, the Grant of the National Center for Child Health and Development, UK, National Cancer Institute (CA021765), US, the American Lebanese Syrian Associated Charities (ALSAC), US, Czech Health Research Council (NU20-07-00322), Czech, the ERA-NET TRANSCAN EJC granted by Fondation ARC, France, the Center for Biological Resources (CRB-cancer; BB-0033-00076) of the Robert Debr{\'e} Hospital, France, and the Oncode Institute and KiKa Foundation, Netherlands. Members of Study Groups. AIEOP: Valentino Conter, Andrea Biondi; Polish ALIC: Wojciech Mlynarski; BFM-A: Georg Mann, Andishe Attarbaschi, Karin Nebral, Sabine Strehl and Dagmar Schinnerl; BFM-G/CH: Martin Schrappe; COG: Stephen Hunger; DCOG: Rob Pieters; JACLS: Junichi Hara, Keizo Horibe; NOPHO: Kjeld Schmiegelow, Mats Heyman; TCCSG: Akira Ohara, Katsuyoshi Koh; TPOG: His-Che Liu; CLIP: Jan Stary; UKALL: Ajay Vora, Claire Schwab; SFCE: Andr{\'e} Baruchel, Yves Bertrand, Marion Strullu, Catherine Paillard, Yves Reguerre, Isabelle Pellier, and Chlo{\'e} Arfeuille. We thank all the members of Ponte di Legno Childhood ALL Working Group. Funding Information: Conflict of interest C.G.M.: Research support from Loxo, Abbvie, Pfizer. Consulting and speaking fees from Amgen, Illumina. C-H Pui received consulting and speaker fees from Amgen, Erytech Phamra, and Servier. H.I. received a research grant from Servier.",
year = "2021",
month = nov,
doi = "10.1038/s41375-021-01199-0",
language = "English",
volume = "35",
pages = "3272--3277",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Springer Nature",
number = "11",
}